Cargando…

Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel

Simultaneously targeted treatment of tumor cells and their surrounding growth-supporting immune cells is a promising strategy to reshape immunosuppressive tumor microenvironment (TME) and potentiate host innate and adaptive antitumor immune responses. Methods: We designed a series of melittin-(RADA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Xiaomeng, Meng, Jingshu, Deng, Suke, Zhang, Lingling, Wan, Chao, Lu, Lisen, Huang, Jing, Hu, Yan, Zhang, Zhanjie, Li, Yan, Lovell, Jonathan F., Wu, Gang, Yang, Kunyu, Jin, Honglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053188/ https://www.ncbi.nlm.nih.gov/pubmed/32194854 http://dx.doi.org/10.7150/thno.42385

Ejemplares similares

USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer
por: Dai, Xiaomeng, et al.
Publicado: (2020)

Irradiated tumor cell–derived microparticles mediate tumor eradication via cell killing and immune reprogramming
por: Wan, Chao, et al.
Publicado: (2020)

Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma
por: Meng, Jingshu, et al.
Publicado: (2023)

Locally Injectable Hydrogels for Tumor Immunotherapy
por: Zhang, Xinyi, et al.
Publicado: (2021)

Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy
por: Khan, Safir Ullah, et al.
Publicado: (2023)

Targeting senescence-like fibroblasts radiosensitizes non–small cell lung cancer and reduces radiation-induced pulmonary fibrosis
por: Meng, Jingshu, et al.
Publicado: (2021)

Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
por: Zeng, Weiwei, et al.
Publicado: (2022)

Engineered Microparticles for Treatment of Murine Brain Metastasis by Reprograming Tumor Microenvironment and Inhibiting MAPK Pathway
por: Lu, Lisen, et al.
Publicado: (2023)

Sustained release of tumor cell lysate and CpG from an injectable, cytotoxic hydrogel for melanoma immunotherapy
por: Yang, Kui, et al.
Publicado: (2023)

Radiated tumor cell-derived microparticles effectively kill stem-like tumor cells by increasing reactive oxygen species
por: Hu, Yan, et al.
Publicado: (2023)

Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling
por: Huang, Jing, et al.
Publicado: (2020)

Mimicking the Endometrial Cancer Tumor Microenvironment to Reprogram Tumor-Associated Macrophages in Disintegrable Supramolecular Gelatin Hydrogel
por: Huang, Yujia, et al.
Publicado: (2020)

Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
por: Genard, Géraldine, et al.
Publicado: (2017)

Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy
por: Zhou, Yuhan, et al.
Publicado: (2021)

Metabolic reprogramming in the immunosuppression of tumor-associated macrophages
por: Wang, Ying, et al.
Publicado: (2022)

Metabolic reprograming of tumor-associated macrophages
por: Puthenveetil, Abhishek, et al.
Publicado: (2020)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment
por: Chen, Zhixiong, et al.
Publicado: (2023)

Application of injectable hydrogels in cancer immunotherapy
por: Liu, Chutong, et al.
Publicado: (2023)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
por: Payne, Kyle K., et al.
Publicado: (2012)

Reprogramming Tumor Associated Macrophage Phenotype by a Polysaccharide from Ilex asprella for Sarcoma Immunotherapy
por: Li, Qiu, et al.
Publicado: (2018)

Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect
por: Cheng, Furong, et al.
Publicado: (2023)

Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy
por: Song, Huijuan, et al.
Publicado: (2019)

Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment
por: Kumar, Sudhir, et al.
Publicado: (2022)

Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment
por: Liu, Yushuai, et al.
Publicado: (2022)

Progress in the application of hydrogels in immunotherapy of gastrointestinal tumors
por: Zheng, Hao, et al.
Publicado: (2023)

Programming Injectable DNA Hydrogels Yields Tumor Microenvironment‐Activatable and Immune‐Instructive Depots for Augmented Chemo‐Immunotherapy
por: Fan, Yu, et al.
Publicado: (2023)

Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
por: Zhao, Lin, et al.
Publicado: (2022)

Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy
por: Luczak, Elizabeth D., et al.
Publicado: (2020)

Chemo-photothermal immunotherapy for eradication of orthotopic tumors and inhibition of metastasis by intratumoral injection of polydopamine versatile hydrogels
por: Zhuang, Bo, et al.
Publicado: (2022)

Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids
por: Suraiya, Anisha B., et al.
Publicado: (2022)

In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy
por: Li, Jiehan, et al.
Publicado: (2022)

Peritoneal resident macrophages in tumor metastasis and immunotherapy
por: Zhang, Yu, et al.
Publicado: (2022)

Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment
por: Wang, Shilin, et al.
Publicado: (2022)

Targeting tumor-associated macrophages to synergize tumor immunotherapy
por: Xiang, Xiaonan, et al.
Publicado: (2021)

Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel
por: Zhuang, Qiuyu, et al.
Publicado: (2023)

Immunotherapy Targeting Tumor-Associated Macrophages
por: Liu, Yafei, et al.
Publicado: (2020)

Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
por: Gu, Jun, et al.
Publicado: (2022)

Oxygen-carrying nanoplatform to reprogram tumor immunosuppressive microenvironment and enhance photothermal-immunotherapy
por: Huang, Ju, et al.
Publicado: (2023)

Corruptive Reprograming of Macrophages into Tumor-Associated Macrophages: The Transcriptional, Epigenetic and Metabolic Basis
por: Ahmad, Aamir
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vqd2bbdjh17snf33tpsmrdpepl